376 related articles for article (PubMed ID: 9674713)
1. High rates of prostate-specific antigen testing in men with evidence of benign prostatic hyperplasia.
Meigs JB; Barry MJ; Giovannucci E; Rimm EB; Stampfer MJ; Kawachi I
Am J Med; 1998 Jun; 104(6):517-25. PubMed ID: 9674713
[TBL] [Abstract][Full Text] [Related]
2. The role of BPH, lower urinary tract symptoms, and PSA levels on erectile function of Brazilian men who undergo prostate cancer screening.
Antunes AA; Srougi M; Dall'oglio MF; Vicentini F; Paranhos M; Freire GC
J Sex Med; 2008 Jul; 5(7):1702-7. PubMed ID: 18194186
[TBL] [Abstract][Full Text] [Related]
3. Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level.
Punglia RS; D'Amico AV; Catalona WJ; Roehl KA; Kuntz KM
Cancer; 2006 Apr; 106(7):1507-13. PubMed ID: 16518812
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the percent free prostate-specific antigen levels in the serum of healthy men and in men with recurrent prostate cancer after radical prostatectomy.
Scorilas A; Yu H; Soosaipillai AR; Gregorakis AK; Diamandis EP
Clin Chim Acta; 2000 Feb; 292(1-2):127-38. PubMed ID: 10686282
[TBL] [Abstract][Full Text] [Related]
5. [PSA testing, biopsy and cancer and benign prostate hyperplasia in France].
Tuppin P; Samson S; Fagot-Campagna A; Lukacs B; Alla F; Allemand H; Paccaud F; Thalabard JC; Vicaut E; Vidaud M; Millat B
Prog Urol; 2014 Jul; 24(9):572-80. PubMed ID: 24975792
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of percentage of free serum prostate-specific antigen to improve specificity of prostate cancer screening.
Catalona WJ; Smith DS; Wolfert RL; Wang TJ; Rittenhouse HG; Ratliff TL; Nadler RB
JAMA; 1995 Oct; 274(15):1214-20. PubMed ID: 7563511
[TBL] [Abstract][Full Text] [Related]
7. Estimation of prostatic growth using serial prostate-specific antigen measurements in men with and without prostate disease.
Carter HB; Morrell CH; Pearson JD; Brant LJ; Plato CC; Metter EJ; Chan DW; Fozard JL; Walsh PC
Cancer Res; 1992 Jun; 52(12):3323-8. PubMed ID: 1375867
[TBL] [Abstract][Full Text] [Related]
8. Interpreting results of prostate-specific antigen testing for early detection of prostate cancer.
Meigs JB; Barry MJ; Oesterling JE; Jacobsen SJ
J Gen Intern Med; 1996 Sep; 11(9):505-12. PubMed ID: 8905498
[TBL] [Abstract][Full Text] [Related]
9. Prostate cancer detection in candidates for open prostatectomy.
Fowler JE; Bigler SA; Kolski JM
J Urol; 1998 Dec; 160(6 Pt 1):2107-10. PubMed ID: 9817333
[TBL] [Abstract][Full Text] [Related]
10. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
11. Detection of prostate cancer and changes in prostate-specific antigen (PSA) six months after surgery for benign prostatic hyperplasia in patients with elevated PSA.
Ozden C; Inal G; Adsan O; Yazici S; Ozturk B; Cetinkaya M
Urol Int; 2003; 71(2):150-3. PubMed ID: 12890951
[TBL] [Abstract][Full Text] [Related]
12. [Prostate-specific antigen. A new biological serum marker for prostatic adenocarcinoma].
Haukaas S; Skaarland E; Halvorsen OJ; Stensland E; Farstad M
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2990-3. PubMed ID: 1700496
[TBL] [Abstract][Full Text] [Related]
13. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
Kato M; Okada K
Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
[TBL] [Abstract][Full Text] [Related]
14. Serum-to-urinary prostate-specific antigen ratio: a potential means of distinguishing benign prostatic hyperplasia from prostate cancer.
Irani J; Millet C; Levillain P; Doré B; Begon F; Aubert J
Eur Urol; 1996; 29(4):407-12. PubMed ID: 8791046
[TBL] [Abstract][Full Text] [Related]
15. Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia.
Scattoni V; Raber M; Montorsi F; Da Pozzo L; Brausi M; Calori G; Freschi M; Rigatti P
Eur Urol; 1999 Dec; 36(6):621-30. PubMed ID: 10559617
[TBL] [Abstract][Full Text] [Related]
16. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
17. [Early diagnosis of prostate carcinoma with reference to the density of prostate-specific antigen].
Schmid HP; Ravery V; Toublanc M; Boccon-Gibod L
Schweiz Med Wochenschr; 1996 Sep; 126(36):1530-5. PubMed ID: 8927956
[TBL] [Abstract][Full Text] [Related]
18. Associations of lower urinary tract symptoms with prostate-specific antigen levels, and screen-detected localized and advanced prostate cancer: a case-control study nested within the UK population-based ProtecT (Prostate testing for cancer and Treatment) study.
Collin SM; Metcalfe C; Donovan J; Lane JA; Davis M; Neal D; Hamdy F; Martin RM
BJU Int; 2008 Nov; 102(10):1400-6. PubMed ID: 18540932
[TBL] [Abstract][Full Text] [Related]
19. Early detection of prostate cancer. Part I: Prior probability and effectiveness of tests. The American College of Physicians.
Coley CM; Barry MJ; Fleming C; Mulley AG
Ann Intern Med; 1997 Mar; 126(5):394-406. PubMed ID: 9054286
[TBL] [Abstract][Full Text] [Related]
20. [Pathological basis for elevation of serum prostate specific antigen].
Xia TL; Deng FM; Feng T
Zhonghua Yi Xue Za Zhi; 1994 May; 74(5):306-8, 327. PubMed ID: 7525028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
